Novartis

Novartis Settles U.S. Bribery Charges
Novartis to Buy AveXis in $8B Gene Therapy Bet
GSK Buys Novartis out of Joint Venture for $13B
Specialty Drug Costs to Soar Again in 2018
Novartis Settles Kickback Charges for $370M
CFO Snapshot: Sweating in Front of the Board
Risk Takers, Career Makers